Lipocine and Verity Pharma Enter into License Agreement for TLANDO® Franchise in the U.S. and Canada
SALT LAKE CITY, Jan. 18, 2024 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company focused on treating Central Nervous System (CNS) disorders, Gordon Silver Limited and Verity ...
ROCKVILLE, Md. and SUZHOU, China, June 14, 2024 /PRNewswire/ -- Ascentage Pharma (6855 HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B ...
Phase 2 proof-of-concept trial with AMO Pharma investigative therapy AMO-02 now underway at 17 sites across Canada; 120 patients expected to enroll ARVC is a rare, inherited cardiomyopathy that can ...
WAYNE, Pa., Dec. 05, 2023 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drugs for immuno-inflammatory diseases, ...
Orchid Pharma, a subsidiary of India’s Dhanuka Labs, has gained a sublicense to manufacture the antibiotic cefiderocol as part of an effort to expand access worldwide. Cefiderocol is used to treat ...
* KATE THERAPEUTICS - DEBUTS $51 MILLION SERIES A FUNDING CO-LED BY FOUNDING INVESTOR WESTLAKE VILLAGE BIOPARTNERS AND VERSANT VENTURES Sign up here. * KATE THERAPEUTICS - GRANTED ASTELLAS PHARMA AN ...
MARSEILLE, France--(BUSINESS WIRE)--Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) today announced that it has entered into an exclusive license agreement with Takeda under which Innate grants ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback